FMODexpression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study


Por: Sorigue, M, Junca, J, Ferra, C, Marce, S, Ruiz-Xiville, N, Pinyol, L, Cabezon, M, Espasa, A, Dominguez, D, Lopez-Viaplana, L, Ruiz, R, Buch, J, Plensa, E, Mostacedo, SZ, Aranda, J, Vergara, S, Raya, M, Granada, I, Tapia, G, Navarro, JT, Bea, S and Zamora, L

Publicada: 1 sep 2020 Ahead of Print: 1 jun 2020
Resumen:
Background Within the hematopoietic compartment, fibromodulin (FMOD) is almost exclusively expressed in chronic lymphocytic leukemia (CLL) lymphocytes. We set out to determine whether FMOD could be of help in diagnosing borderline lymphoproliferative disorders (LPD). Methods We established 3 flow cytometry-defined groups (CLL [n= 65], borderline LPD [n= 28], broadly defined as those with CLLflow score between 35 and -20 or discordant CD43 and CLLflow, and non-CLL LPD [n= 40]). FMOD expression levels were determined by standard RT-PCR in whole-blood samples. Patients were included regardless of lymphocyte count but with tumor burden >= 40%. Results FMOD expression levels distinguished between CLL (median 98.5, interquartile range [IQR] 37.8-195.1) and non-CLL LPD (median 0.012, IQR 0.003-0.033) with a sensitivity and specificity of 1. Most borderline LPDs were CD5/CD23/CD200-positive with no loss of B-cell antigens and negative or partial expression of CD43. 16/22 patients with available cytogenetic analysis showed trisomy 12. In 25/28 (89%) of these patients, FMOD expression levels fell between CLL and non-CLL (median 3.58, IQR 1.06-6.21). Discussion This study could suggest that borderline LPDs may constitute a distinct group laying in the biological spectrum of chronic leukemic LPDs. Future studies will have to confirm these results with other biological data. Quantification of FMOD can potentially be of help in the diagnosis of phenotypically complex LPDs.

Filiaciones:
:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Dept Clin Haematol, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

Pinyol, L:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

Espasa, A:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

Lopez-Viaplana, L:
 Hosp Mataro, Dept Hematol, Barcelona, Spain

Ruiz, R:
 Inst Josep Carreres Leucemia, Badalona, Spain

Buch, J:
 Hosp Calella, Dept Hematol, Calella, Spain

 ICO Girona, Girona, Spain

Plensa, E:
 Hosp Mataro, Dept Hematol, Barcelona, Spain

Mostacedo, SZ:
 Hosp Calella, Dept Hematol, Calella, Spain

 ICO Girona, Girona, Spain

Aranda, J:
 Inst Josep Carreres Leucemia, Badalona, Spain

Vergara, S:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

Raya, M:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

:
 Hosp Badalona Germans Trias & Pujol, Dept Pathol, Badalona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain

Bea, S:
 Inst Invest Biomed August Pi & Sunyer IDIBAP, Barcelona, Spain

 Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain

 Univ Barcelona, Barcelona, Spain

:
 Univ Autonoma Barcelona, ICO Hosp Germans Trias & Pujol, Inst Recerca Josep Carreras, Hematol Lab, Badalona, Spain
ISSN: 15524949





CYTOMETRY PART B-CLINICAL CYTOMETRY
Editorial
John Wiley & Sons Ltd., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: 98 Número: 5
Páginas: 421-428
WOS Id: 000539745800001
ID de PubMed: 32530577

MÉTRICAS